MESO FY 2010 Earnings — Mesoblast Limited Revenue & Financial Results | Market Cap Arena

MESOMesoblast Limited

$2B

FY 2010 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$5,500-99.4% YoY

Gross Profit

$5,500100.0% margin

Operating Income

-$10M-188851.8% margin

Net Income

-$15M-268743.5% margin

EPS (Diluted)

$-0.27

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$10M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$40M

Total Liabilities

$2M

Stockholders' Equity

$38M

Cash & Equivalents

$32M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5,500	$890,708	-99.4%
Gross Profit	$5,500	$890,708	-99.4%
Operating Income	-$10M	-$9M	-10.2%
Net Income	-$15M	-$12M	-20.3%